Back to Market返回行情

LFWD Lifeward Ltd.

USHealthcare
$8.44+3.91%ClosedMarket Cap: $13.6M

As of 2026-07-09 16:00

Why LFWD matters now

Lifeward Ltd. (LFWD) is a US stock in Healthcare. The latest InvestLog snapshot shows $8.44 with +3.91% on the session and $13.6M in market capitalization; recent performance reads 1-month +7.97% and YTD -0.14%.

The latest financial table shown here is Q1 2026, with revenue of $3.9M, net income of $-10.8M, and EPS of $-6.70. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -134.9%.

The latest indexable market news headline is "Lifeward Secures Growth Capital to Accelerate Commercial Expansion with Up to $11.2 Million in Strategic Financing" from GlobeNewsWire.

Additional event context on this page matters because analyst consensus is Buy with a median target of $129.00; recent insider activity includes Rose Keith Dale filing . These signals are research inputs, not a recommendation.

Valuation

P/E (TTM)

PEG

P/B

1.77

P/S

0.53

EV/EBITDA

-0.50

DCF Value

$-223.14

FCF Yield

-134.9%

Div Yield

0.0%

Margins & Returns

Gross Margin

36.6%

Operating Margin

-120.3%

Net Margin

-123.7%

ROE

-243.1%

ROA

-77.4%

ROIC

-86.3%

Financials

PeriodRevenueNet IncomeEPS
Q1 2026$3.9M$-10.8M$-6.70
Q4 2025$5.1M$-5.3M$-3.60
FY 2025$22.0M$-19.9M$-17.16
Q3 2025$6.2M$-3.2M$-2.40

Analyst Ratings

Consensus

Buy

Target (Consensus)

$129.00

Target (Median)

$129.00

Target Range

$102.00 - $156.00

Strong Buy: 1Buy: 1Hold: 0Sell: 0Strong Sell: 0
HC Wainwright & Co.Buy
2026-03-19
HC Wainwright & Co.Buy
2025-11-18

Trading Activity

Insider Trades

Rose Keith Daleofficer: Chief Medical Officer
Sell2026-05-20
Rose Keith Daleofficer: Chief Medical Officer
Sell2026-05-20
ORAMED PHARMACEUTICALS INC.10 percent owner
Sell2026-05-14
ORAMED PHARMACEUTICALS INC.10 percent owner
Sell2026-05-14
ORAMED PHARMACEUTICALS INC.10 percent owner
Sell2026-05-14

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

IL

Exchange

Beta

0.37

Lifeward Ltd. is a healthcare technology company specializing in the creation, development, and commercialization of wearable robotic exoskeletons. These sophisticated devices are engineered to restore lower limb mobility for individuals living with spinal cord injuries (SCI), granting them the ability to stand, walk, pivot, and navigate staircases by providing assistive hip and knee motion. Key offerings from the company include the ReWalk Exo-Suit and the ReWalk Personal 6.0. Founded by Amit Goffer on June 20, 2001, the enterprise maintains its corporate headquarters in Marlborough, Massachusetts.